BackTable / Urology / Contributor
Dr. Claus Roehrborn
Dr. Claus Roehrborn is a urologist with UT Southwestern in Dallas, Texas.
Listen to Dr. Claus Roehrborn on the BackTable Urology Podcast
The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Claus Roehrborn and get practical advice on how to build your practice by listening to the BackTable Urology Podcast.
Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs.
Follow the button below to get started with CMEfy.
Stay Up To Date
About Dr. Claus Roehrborn
A world-renowned urologist and expert on cancerous prostate diseases, Claus Roehrborn, M.D., has been practicing at UT Southwestern for more than 20 years and has been Chair of the Department of Urology since 2002. Under his leadership, the Department has consistently been named among the nation’s best by U.S. News & World Report.
Dr. Roehrborn’s practice focuses on the treatment of prostate cancer and benign prostatic hyperplasia (BPH). Over the past several years, he has performed more than 1,200 robotic prostatectomies for prostate cancer and more than 800 laser prostatectomies for BPH, making him one of the country’s most experienced surgeons in the use of robotic procedures for urologic conditions. In addition, he is involved in virtually all aspects of BPH research as well as translational and clinical research in prostatitis and prostate cancer.
Born and raised in the former West Germany, Dr. Roehrborn earned his medical degree from Justus Liebig University in Giessen and began his residency in surgery and urology at the German Army Hospital there. He was initially drawn to urology during medical school because of the comprehensive nature of the specialty that allows physicians to see patients, do their own medical tests, diagnose their conditions, operate on them if necessary, and then do follow-up care.
In 1984 Dr. Roehrborn moved to Dallas and continued his studies at UT Southwestern where he received advanced training in urologic endocrinology. He became a faculty member of UT Southwestern in 1992.
Dr. Roehrborn has been included in D Magazine's Best Doctors list and was named a Super Doctor by Texas Monthly. In 2010, he was the recipient of the Patricia and William L. Watson Jr., M.D., Award for Excellence in Clinical Medicine, which recognizes a UT Southwestern clinician whose work exemplifies a commitment to outstanding patient care and advancement of innovative medical therapy. The recipient of the award is chosen by a panel of colleagues and peers.
Learn more by visiting Dr. Claus Roehrborn's practice:
Podcasts Featuring Dr. Claus Roehrborn
Urologist Dr. Claus Roehrborn and Interventional Radiologist Dr. Sandeep Bagla discuss the pros and cons of Prostate Artery Embolization (PAE) compared to other Minimally Invasive Surgical Treatments (MISTS) for Benign Prostate Hyperplasia (BPH). They also discuss the importance of a collaborative, multidisciplinary approach when offering these treatment options, including agreeing on the best treatment for the patient.
In Part II, Dr. Aditya Bagrodia talks with Dr. Claus Roehrborn of UT Southwestern Medical Center about the surgical management of benign prostatic hyperplasia (BPH).
In Part I, Dr. Aditya Bagrodia talks with Dr. Claus Roehrborn of UT Southwestern Medical Center about the medical management of benign prostatic hyperplasia (BPH).
Articles Featuring Dr. Claus Roehrborn
The HoLEP procedure, or holmium laser enucleation of the prostate, is a new BPH treatment that is widely used because of its minimal invasiveness and quicker recovery times. However, urologists should evaluate the HoLEP procedure pros and cons before they decide on the surgery.
The bipolar TURP procedure involves the use of a bipolar current to resect excess prostate tissue, alleviating symptoms in patients with benign prostate hyperplasia (BPH). Learn about Bipolar TURP procedure steps, advantages of the procedure, and complications.
The International Prostate Symptom Score (IPSS) is a universal assessment endorsed by the AUA. The IPSS questionnaire consists of 7 questions and evaluates BPH patients from a score of 0 to 35.
5-alpha reductase inhibitors are a class of medications commonly used to treat BPH. They are most effective in BPH patients with large prostates. Learn more about using 5-alpha reductase inhibitors for BPH.
Thank you for listening! If you have a question for Dr. Claus Roehrborn about a topic discussed on the BackTable Urology Podcast, you can get in touch with this form. Please note that our contributors are not able to respond to every inquiry.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.